• Fund Type: ETF
  • Objective: Health Care
  • Asset Class: Equity
  • Geographic Focus: U.S.

SPDR S&P Pharmaceuticals ETF

+ Add to Watchlist

XPH:US

101.1200 USD 0.5900 0.59%

As of 16:15:05 ET on 08/22/2014.

Snapshot for SPDR S&P Pharmaceuticals ETF (XPH)

Open: 100.5000 High - Low: 101.3000 - 100.1400 Primary Exchange: NYSE Arca
Volume: 22,088 52-Week Range: 73.0634 - 106.7600 Beta vs SPSIPHTR: 1.0016

ETF Chart for XPH

No chart data available.
  • XPH:US 101.1200
  • 1D
  • 1M
  • 1Y
100.5300
Interactive XPH Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for XPH

SPDR Pharmaceuticals ETF is an exchange-traded fund incorporated in the USA. The Fund's objective is to replicate as closely as possible the performance of the S&P Pharmaceuticals Select Industry Index, an equal-weighted index.

Inception Date: 2006-06-22 Telephone: 1-866-787-2257
Managers: JOHN A TUCKER
Web Site: www.spdrs.com

Fundamentals for XPH

NAV (on 2014-08-21) 100.4826
Assets (M) (on 2014-08-21) 894.3085
Shares out (M) 8.90
Market Cap (M) 899.98
% Premium 0.05
Average 52-Week % Premium 0.0131
Fund Leveraged N

Dividends for XPH

Dividend Type Income
Dividend Frequency Quarter
Last Dividend Net (on 2014-06-20) 0.1351
Dividend Yield (ttm) 1.80%

Performance for XPH

1-Month +0.86% 1-Year +36.40%
3-Month +5.29% 3-Year +33.95%
Year To Date +14.59% 5-Year +26.78%
Expense Ratio 0.35

Top Fund Holdings for XPH

Filing Date: 08/21/2014
Name Position Value % of Total
Salix Pharmaceuticals Ltd 269,659 42,687,020 4.779%
Akorn Inc 1,089,076 40,894,804 4.578%
Pacira Pharmaceuticals Inc/DE 368,199 37,928,179 4.246%
Jazz Pharmaceuticals PLC 212,971 33,566,359 3.758%
Depomed Inc 2,262,965 32,971,400 3.691%
Zoetis Inc 940,970 32,830,443 3.675%
Actavis plc 144,624 32,721,180 3.663%
Hospira Inc 594,907 32,565,209 3.645%
Bristol-Myers Squibb Co 641,850 32,086,082 3.592%
Eli Lilly & Co 513,161 31,831,377 3.563%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil